Pampalone, M.; Vitale, G.; Gruttadauria, S.; Amico, G.; Iannolo, G.; Douradinha, B.; Mularoni, A.; Conaldi, P.G.; Pietrosi, G.
Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant Enterobacterales in Decompensated Cirrhosis. Int. J. Mol. Sci. 2022, 23, 857.
https://doi.org/10.3390/ijms23020857
AMA Style
Pampalone M, Vitale G, Gruttadauria S, Amico G, Iannolo G, Douradinha B, Mularoni A, Conaldi PG, Pietrosi G.
Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant Enterobacterales in Decompensated Cirrhosis. International Journal of Molecular Sciences. 2022; 23(2):857.
https://doi.org/10.3390/ijms23020857
Chicago/Turabian Style
Pampalone, Mariangela, Giampiero Vitale, Salvatore Gruttadauria, Giandomenico Amico, Gioacchin Iannolo, Bruno Douradinha, Alessandra Mularoni, Pier Giulio Conaldi, and Giada Pietrosi.
2022. "Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant Enterobacterales in Decompensated Cirrhosis" International Journal of Molecular Sciences 23, no. 2: 857.
https://doi.org/10.3390/ijms23020857
APA Style
Pampalone, M., Vitale, G., Gruttadauria, S., Amico, G., Iannolo, G., Douradinha, B., Mularoni, A., Conaldi, P. G., & Pietrosi, G.
(2022). Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant Enterobacterales in Decompensated Cirrhosis. International Journal of Molecular Sciences, 23(2), 857.
https://doi.org/10.3390/ijms23020857
